Jagannath Pandharinath Tompe has stepped into a critical leadership position as Manager – Audit and Compliance [Expert GMP Auditor] – Corporate Quality Assurance at Zydus Group, bringing with him nearly two decades of unparalleled expertise in pharmaceutical quality systems, validation, and GMP auditing. Based in Ahmedabad, he now leads strategic compliance initiatives across Zydus’ global manufacturing operations, ensuring world-class audit readiness and regulatory excellence.
In his current role, Jagannath is responsible for driving a risk-based global audit strategy, leading GMP audits at high-risk and complex manufacturing sites, and serving as a subject matter expert in sterile manufacturing and biologics. He also mentors junior auditors, provides regulatory guidance, and ensures timely CAPA implementations, aligning site responses with industry standards via the Zy-ACTM (Zydus-Audit Compliance Team Management) platform. His role is instrumental in maintaining Zydus’ mission of delivering high-quality, affordable healthcare solutions to patients worldwide.
Prior to joining Zydus, Jagannath served as Group Leader – Corporate Validation Group at Viatris, where he excelled in overseeing validation strategies, commissioning and qualification of pharmaceutical systems, and GMP compliance across global facilities. His contributions extended to cleaning validation, HVAC and utility systems, BMS/EMS qualification, and regulatory documentation—a testament to his holistic understanding of pharmaceutical validation lifecycles.
Jagannath’s journey also includes key roles at Pfizer, Mylan, Hospira, Cipla, and Naprod Life Sciences, where he consistently elevated QA standards and led major commissioning and audit-readiness projects. He is well-versed in tools such as FMEA, QRM, SDLC, VLC, and CAPA systems, and is known for fostering operational efficiency and compliance in both greenfield and commercial setups.
With this latest move, Jagannath Pandharinath Tompe is set to reinforce Zydus Group’s commitment to regulatory excellence, operational rigor, and global quality leadership—ensuring the organization’s systems not only meet but exceed evolving global standards in pharmaceutical manufacturing and quality assurance.